Botwood Nicholas A.J. — SEC Form 4 filings

SEC reporting owner CIK 2066784. 3 Form 4 filings on record with FilingPulse; latest filed 2026-06-12.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2025-05-19 to 2026-06-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Syndax Pharmaceuticals Inc (SNDX)Head of R&D, CMO31 leg · 11,765 sh · $105,8262 legs · 65,515 sh · $1,183,6437

Form 4 filings — Botwood Nicholas A.J.

FiledFormIssuerReported transactionsSource
2026-06-124Syndax Pharmaceuticals Inc (SNDX)Option exercise (M): 22,515 @ $13.82 · Sale (S): 34,280 @ $18 · Option exercise (M): 31,235 @ $13.82 · Sale (S): 31,235 @ $18.14 · Option exercise (M): 22,515 (derivative) @ $0 · Option exercise (M): 31,235 (derivative) @ $0EDGAR
2026-02-064Syndax Pharmaceuticals Inc (SNDX)Grant/award (A): 24,000 @ $0 · Grant/award (A): 36,000 @ $0 · Grant/award (A): 144,700 (derivative) @ $20.43EDGAR
2025-05-194Syndax Pharmaceuticals Inc (SNDX)Purchase (P): 11,765 @ $8.99EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2066784 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →